<DOC>
	<DOCNO>NCT00007943</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness gemcitabine treat patient advanced colorectal cancer .</brief_summary>
	<brief_title>Gemcitabine Treating Patients With Advanced Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate patient advance colorectal cancer treat gemcitabine . - Determine toxic effect drug patient . - Determine progression-free survival patient treated drug . OUTLINE : This multicenter study . Patients receive gemcitabine IV continuously 24 hour day 1 , 8 , 15 . Treatment repeat every 28 day total 6 course absence disease progression unacceptable toxicity . Patients follow every 6 month . PROJECTED ACCRUAL : A total 12-41 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced colorectal cancer fail least 1 prior course fluoropyrimidinebased chemotherapy Measurable and/or evaluable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : 02 Life expectancy : At least 3 month Hematopoietic : WBC least 3,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2.5 time upper limit normal ( ULN ) ALT and/or AST great 3 time ULN ( great 10 time ULN secondary hepatic involvement tumor Renal : Creatinine great 2.0 mg/dL Cardiovascular : No history cardiac arrhythmia require chronic treatment beyond acute event ( e.g. , arrhythmias severe electrolyte abnormality allow ) No active cardiac disease require treatment hypertension , stable angina , chronic valvular disease Other : No malignancy within past 5 year except curatively treat ( include surgically cure ) cancer No serious medical psychiatric illness would preclude study No active uncontrolled bacterial , fungal , viral infection Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics No 3 prior chemotherapy regimen Must 1 prior fluorouracilbased regimen 1 cytotoxic agent ( e.g. , irinotecan ) More 4 week since prior chemotherapy Prior gemcitabine allow No concurrent antineoplastic therapy Endocrine therapy : Not specify Radiotherapy : More 4 week since prior radiotherapy Surgery : More 4 week since prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>